Then, we conducted in vitro assays and in vivo experiments, and the results demonstrated that knock‐down PTBP1 in CISR osteosarcoma cells enhances the anti‐tumour effect of cisplatin. The gene discussed is PTBP1; the disease is osteosarcoma.